These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31085741)

  • 21. Plasma xanthine oxidoreductase activity in Japanese patients with type 2 diabetes across hospitalized treatment.
    Kawachi Y; Fujishima Y; Nishizawa H; Nagao H; Nakamura T; Akari S; Murase T; Taya N; Omori K; Miyake A; Fukuda S; Takahara M; Kita S; Katakami N; Maeda N; Shimomura I
    J Diabetes Investig; 2021 Aug; 12(8):1512-1520. PubMed ID: 33211396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential regulation of hypoxanthine and xanthine by obesity in a general population.
    Furuhashi M; Koyama M; Higashiura Y; Murase T; Nakamura T; Matsumoto M; Sakai A; Ohnishi H; Tanaka M; Saitoh S; Moniwa N; Shimamoto K; Miura T
    J Diabetes Investig; 2020 Jul; 11(4):878-887. PubMed ID: 31916414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xanthine oxidoreductase activity in marathon runners: potential implications for marathon-induced acute kidney injury.
    Kosaki K; Kumamoto S; Tokinoya K; Yoshida Y; Sugaya T; Murase T; Akari S; Nakamura T; Nabekura Y; Takekoshi K; Maeda S
    J Appl Physiol (1985); 2022 Jul; 133(1):1-10. PubMed ID: 35608201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of xanthine oxidoreductase and uric acid in metabolic syndrome.
    Battelli MG; Bortolotti M; Polito L; Bolognesi A
    Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2557-2565. PubMed ID: 29733945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma xanthine oxidoreductase activity in patients with decompensated acute heart failure requiring intensive care.
    Okazaki H; Shirakabe A; Matsushita M; Shibata Y; Sawatani T; Uchiyama S; Tani K; Murase T; Nakamura T; Takayasu T; Asano M; Kobayashi N; Hata N; Asai K; Shimizu W
    ESC Heart Fail; 2019 Apr; 6(2):336-343. PubMed ID: 30620450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma xanthine oxidoreductase activity change over 12 months independently associated with change in serum uric acid level: MedCity21 health examination registry.
    Kurajoh M; Fukumoto S; Murase T; Nakamura T; Nagata Y; Nakatani S; Tsuda A; Yamada S; Morioka T; Mori K; Imanishi Y; Kawada N; Hirata K; Emoto M
    Clin Chem Lab Med; 2021 Mar; 59(4):e137-e140. PubMed ID: 32735550
    [No Abstract]   [Full Text] [Related]  

  • 27. Association between Plasma Xanthine Oxidoreductase Activity and the Renal Function in a General Japanese Population: The Tohoku Medical Megabank Community-Based Cohort Study.
    Taguchi S; Nasu T; Satoh M; Kotozaki Y; Tanno K; Tanaka F; Asahi K; Ohmomo H; Kikuchi H; Kobayashi T; Morino Y; Shimizu A; Sobue K; Sasaki M
    Kidney Blood Press Res; 2022; 47(12):722-728. PubMed ID: 36318900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma xanthine oxidoreductase (XOR) activity in patients who require cardiovascular intensive care.
    Shibata Y; Shirakabe A; Okazaki H; Matsushita M; Goda H; Shigihara S; Asano K; Kiuchi K; Tani K; Murase T; Nakamura T; Kobayashi N; Hata N; Asai K; Shimizu W
    Heart Vessels; 2020 Oct; 35(10):1390-1400. PubMed ID: 32342210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The significance of serum xanthine oxidoreductase in patients with nonalcoholic fatty liver disease.
    Zhang J; Xu C; Zhao Y; Chen Y
    Clin Lab; 2014; 60(8):1301-7. PubMed ID: 25185415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of plasma xanthine oxidoreductase activity with severity and clinical outcome in patients with chronic heart failure.
    Otaki Y; Watanabe T; Kinoshita D; Yokoyama M; Takahashi T; Toshima T; Sugai T; Murase T; Nakamura T; Nishiyama S; Takahashi H; Arimoto T; Shishido T; Miyamoto T; Kubota I
    Int J Cardiol; 2017 Feb; 228():151-157. PubMed ID: 27865177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity.
    Furuhashi M
    Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E827-E834. PubMed ID: 32893671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations of circulating xanthine oxidoreductase activity with cardiometabolic risk markers in overweight and obese Japanese men: a cross-sectional pilot study.
    Kosaki K; Yokota A; Tanahashi K; Myoenzono K; Park J; Yoshikawa T; Yoshida Y; Murase T; Akari S; Nakamura T; Maeda S
    J Clin Biochem Nutr; 2022 Sep; 71(2):122-128. PubMed ID: 36213790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Plasma Xanthine Oxidoreductase with Arterial Stiffness in Type 2 Diabetes with Liver Dysfunction.
    Ohira M; Tanaka S; Watanabe Y; Nakamura S; Oka R; Yamaguchi T; Ban N; Saiki A; Ishihara N; Murano T; Murase T; Nakamura T; Tatsuno I
    Am J Med Sci; 2022 Mar; 363(3):242-250. PubMed ID: 34619144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic Endothelial Function, Plasma Xanthine Oxidoreductase Activity, and Blood Pressure Variability in Patients with Stable Coronary Artery Disease.
    Hiraga T; Saito Y; Tateishi K; Mori N; Murase T; Nakamura T; Akari S; Saito K; Kitahara H; Kobayashi Y
    Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of xanthine oxidoreductase inhibitor, topiroxostat, on body weight of diabetic obese mice.
    Nakamura T; Nampei M; Murase T; Satoh E; Akari S; Katoh N; Mizukami H
    Nutr Diabetes; 2021 Apr; 11(1):12. PubMed ID: 33850106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Newly Developed Method-Based Xanthine Oxidoreductase Activities in Various Human Liver Diseases.
    Sato K; Naganuma A; Nagashima T; Arai Y; Mikami Y; Nakajima Y; Kanayama Y; Murakami T; Uehara S; Uehara D; Yamazaki Y; Murase T; Nakamura T; Uraoka T
    Biomedicines; 2023 May; 11(5):. PubMed ID: 37239117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of Patients with an Abnormally Decreased Plasma Xanthine Oxidoreductase Activity in Acute Heart Failure Who Visited the Emergency Department.
    Shirakabe A; Okazaki H; Matsushita M; Shibata Y; Goda H; Shigihara S; Asano K; Tani K; Kiuchi K; Murase T; Nakamura T; Kobayashi N; Hata N; Asai K; Shimizu W
    Cardiology; 2020; 145(8):473-480. PubMed ID: 32615578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased plasma xanthine oxidoreductase activity deteriorates coronary artery spasm.
    Watanabe K; Shishido T; Otaki Y; Watanabe T; Sugai T; Toshima T; Takahashi T; Yokoyama M; Kinoshita D; Murase T; Nakamura T; Wanezaki M; Tamura H; Nishiyama S; Takahashi H; Arimoto T; Yamauchi S; Yamanaka T; Miyamoto T; Kubota I; Watanabe M
    Heart Vessels; 2019 Jan; 34(1):1-8. PubMed ID: 29936631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of allopurinol on uric acid concentrations, xanthine oxidoreductase activity and oxidative stress in broiler chickens.
    Carro MD; Falkenstein E; Radke WJ; Klandorf H
    Comp Biochem Physiol C Toxicol Pharmacol; 2010 Jan; 151(1):12-7. PubMed ID: 19654053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Xanthine oxidoreductase activity correlates with vascular endothelial dysfunction in patients with type 1 diabetes.
    Washio K; Kusunoki Y; Tsunoda T; Osugi K; Ohigashi M; Murase T; Nakamura T; Matsuo T; Konishi K; Katsuno T; Namba M; Koyama H
    Acta Diabetol; 2020 Jan; 57(1):31-39. PubMed ID: 31093763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.